EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Lannett Co's enterprise value is $593.4 Mil.
Lannett Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2023 was $310.7 Mil. Therefore, Lannett Co's EV-to-Revenue for today is 1.91.
The historical rank and industry rank for Lannett Co's EV-to-Revenue or its related term are showing as below:
LCINQ'
s EV-to-Revenue Range Over the Past 10 Years
Min: 1.12 Med: 1.97 Max: 7.8
Current: 1.91
During the past 13 years, the highest EV-to-Revenue of Lannett Co was 7.80. The lowest was 1.12. And the median was 1.97.
LCINQ's EV-to-Revenue is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.38
vs LCINQ: 1.91
As of today (2024-05-07), Lannett Co's stock price is $0.02965.
Lannett Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2023 was $30.31. Therefore, Lannett Co's PS Ratio for today is 0.00.
Lannett Co EV-to-Revenue Historical Data
The historical data trend for Lannett Co's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Lannett Co's EV-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Lannett Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lannett Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Lannett Co's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Lannett Co's EV-to-Revenue falls into.
Lannett Co's current Enterprise Value is $593.4 Mil.
Lannett Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $310.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lannett Co (OTCPK:LCINQ) EV-to-Revenue Explanation
Lannett Co's share price for today is $0.02965.
Lannett Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $30.31.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lannett Co EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Lannett Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Lannett Co Inc develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products. It offers solid oral, extended-release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages. In addition, the company also provides its products for various medical indications comprising glaucoma, gastrointestinal, migraine, obesity, respiratory, and others. It operates in the segment of generic pharmaceuticals. Its customers include generic pharmaceutical distributors, drug wholesalers, chain drug stores, private label distributors, mail-order pharmacies, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LCINQ has been successfully added to your 